Related by context. All words. (Click for frequent words.) 74 kidney urologic 73 ASPIRE HIGHER 70 MKC# MKC# PP 70 Liprotamase 69 TTR amyloidosis 69 CYT# potent vascular disrupting 69 JAK inhibitor 69 Immunotherapeutic 69 Ceflatonin R 69 inflammatory demyelinating 69 multicenter Phase II 69 Teplizumab 69 Cetrorelix 68 FOLOTYN ® 68 RNAi therapeutic targeting 68 rheumatoid arthritis psoriatic arthritis 68 Daclizumab 68 antibacterial therapeutics 67 INSPIRE Trial Phase III 67 glucokinase activator 67 phase IIb trial 67 immunological diseases 67 thetreatment 67 sunitinib malate 67 Friedreich Ataxia FRDA 67 Ridaforolimus 67 Sudhir Agrawal D.Phil 67 YONDELIS R 67 BioNumerik 67 YONDELIS 67 psoriasis rheumatoid arthritis 67 MKC# MT 67 phase IIb clinical 67 SUTENT ® 67 rALLy clinical trial 67 LymphoStat B belimumab 67 myelofibrosis polycythemia vera 67 OncoVex 67 Trandolapril 67 ALN RSV program 66 Combivir Kivexa 66 Phase #b/#a clinical 66 acyclovir Lauriad R 66 targeted radiotherapeutic 66 HeFH 66 Fludara ® 66 direct renin inhibition 66 acetonide FA 66 Phase IIb clinical trials 66 Fabry Disease 66 GW# [003] 66 tiapamil 66 oncolytic virus therapies 66 reslizumab 66 ADP receptor antagonist 66 therapeutic monoclonal antibody 66 essential thrombocythemia ET 66 investigational therapies 66 leukotriene pathway 66 Omacetaxine 66 PHX# 66 Myelodysplastic syndromes MDS 66 Prodarsan R 66 Regado Biosciences 66 Eraxis 66 Monoclonal antibody 66 immatics 66 IMiDs ® compound 66 Lenocta 66 either acutely decompensated 66 Deforolimus 66 sapacitabine CYC# 66 receptor tyrosine kinase inhibitor 66 Factor VIIa 66 myeloproliferative disorders 66 antibody MAb 66 non alcoholic steatohepatitis 66 immuno inflammatory diseases 66 ALN HPN 66 investigational compounds 66 transthyretin TTR mediated amyloidosis 66 IMiDs R 66 RhuDex ® 66 JAK2 inhibitor 66 TACI Ig 66 romazarit 66 PANVAC VF 66 GTC recombinant human 66 tubulin inhibitor 66 Microplasmin 65 RELOVAIR ™ 65 AEG# 65 recurrent glioblastoma multiforme 65 IMA# 65 SNT MC# 65 chronic myocardial ischemia 65 ketolide antibiotic 65 Xanafide 65 Nexavar sorafenib 65 cardiometabolic disorders 65 immune modulating 65 Campath ® 65 LEUKINE 65 docetaxel Taxotere ® 65 selective androgen receptor modulators 65 HuMax TAC 65 histone deacetylase inhibitor 65 vinca alkaloid 65 Pervasis 65 NTDDS 65 HCV protease inhibitor 65 oral mTOR inhibitor 65 novel VDA molecule 65 vaginally administered lidocaine 65 PDE# inhibitors 65 Sebivo 65 personalized cellular immunotherapy 65 Rebif ® 65 Virulizin ® 65 Renal Cell Carcinoma RCC 65 docetaxel Taxotere R 65 SinuNase ™ 65 P#X# antagonist 65 OMP #R# 65 CytoFabTM 65 HQK 65 aripiprazole Abilify 65 TNFerade TM 65 Abbokinase 65 Squalamine 65 dyslipidemia hypertension diabetes 65 OHR/AVR# 65 IL# PE#QQR 65 Evoltra ® 65 CytoFab 65 hepatitis C HCV 65 MOVIPREP R 65 forodesine 65 phase IIa clinical 65 sodium thiosulfate STS 65 synthetic retinoid 65 disease CDAD 65 CTAP# Capsules 65 neuropsychiatric diseases 65 systemic sclerosis SSc 65 STEDESA 65 Sezary syndrome 65 ZFP Therapeutics 65 oral Janus kinase 65 Deferiprone 65 elotuzumab 65 relapsed MM 65 ALN PCS 65 deforolimus 65 Golimumab 65 Hedgehog Pathway Inhibitor 65 chimeric monoclonal antibody 65 AFREZZA TM 65 solid organ transplantation 64 Personalized Immunotherapy 64 liver cancers hypercholesterolemia 64 cat dander allergy 64 HuLuc# 64 prokinetic agent 64 MAGE A3 ASCI 64 Afatinib 64 Aviptadil 64 Myocet 64 investigational monoclonal antibody 64 anti secretory 64 LHRH antagonists 64 QUADRAMET R 64 methylnaltrexone bromide 64 Vidofludimus 64 haematological malignancies 64 PDX pralatrexate 64 riociguat 64 drug ISA# 64 Chronic lymphocytic leukemia 64 Zorbtive TM 64 AAG geldanamycin analog 64 Actimmune ® 64 familial amyloidotic polyneuropathy FAP 64 psoriasis Crohn disease 64 evaluating REVLIMID 64 investigational humanized monoclonal antibody 64 nicotinic alpha 7 64 AA Amyloidosis 64 TYZEKA 64 Icatibant 64 evaluating tivozanib 64 gepirone ER 64 Archexin 64 Cethromycin 64 phase III isavuconazole 64 acadesine 64 NV1FGF 64 Adnectin 64 Shigamabs ® 64 Ception Therapeutics 64 MTP inhibitor 64 IMC #B 64 anticancer therapeutics 64 Idiopathic pulmonary fibrosis 64 Morquio 64 developing TB4 64 Panzem R 64 metastatic neuroendocrine tumors 64 including eniluracil ADH 64 apricitabine ATC 64 proteasome inhibitor 64 Hereditary angioedema HAE 64 Kamada AAT 64 ophthalmology oncology 64 oxypurinol 64 PRT# 64 Pirfenidone 64 microtubule inhibitor 64 psoriasis psoriatic arthritis 64 JAK inhibitors 64 CCR9 antagonist 64 gastro intestinal inflammation 64 Aflibercept 64 adult chronic ITP 64 fibrotic disorders 64 constipation OIC 64 pan HDAC inhibitor 64 mTOR mammalian target 64 constipation predominant irritable bowel 64 lupus nephritis 64 THR beta agonist 64 Lixivaptan 64 IMiDs ® 64 lenalidomide Revlimid R 64 INS# [001] 64 vapreotide acetate 64 brivaracetam 64 Urocortin 2 64 Kuvan sapropterin dihydrochloride 64 polycythemia vera PV 64 Hepatocellular Carcinoma HCC 64 fostamatinib 64 INTEGRILIN 64 histone deacetylase HDAC 64 Phase Ib II 64 Zalypsis 64 liposomal formulation 64 Cerimon 64 vitro pharmacology 64 AA amyloidosis 64 EHT AGN 64 AMPK activators 64 cyclophilin inhibitors 64 Pyridorin 64 Tasimelteon 64 SinuNase TM 64 chronic thromboembolic pulmonary 64 vosaroxin 64 commercialize deforolimus 64 endothelin receptor antagonists 64 Pazopanib 64 immuno modulatory 64 mertansine 64 novel oral anticoagulant 64 BrachySil TM 64 neuroendocrine cancers 64 cardiometabolic diseases 64 R Saizen R 64 sorafenib Nexavar 64 Oracea TM 64 papillary renal cell carcinoma 64 Simulect 64 Systemic lupus erythematosus 64 lexidronam injection 64 Bucindolol 64 Nanobody ® 64 NS5b 64 Vascular Wrap TM 64 adrenergic regulation 64 TRO# 64 DAPT Study 64 PrevOnco 64 LUMINATE 64 direct thrombin inhibitors 64 lorvotuzumab mertansine 64 NABTT 64 rasagiline tablets 63 thalidomide Thalomid 63 hypoxia activated prodrug 63 renin inhibition 63 essential thrombocythemia 63 Exelixis XL# 63 NP2 Enkephalin 63 tranilast 63 AVAPRO 63 Onconase 63 Allovectin 7 ® 63 Wellstat 63 registrational 63 induced macular edema 63 Inc. Nasdaq NLTX 63 MYCAMINE 63 diarrhea predominant irritable 63 orally administered inhibitor 63 polycythemia vera essential thrombocythemia 63 midstage clinical 63 rheumatoid arthritis thrombocytopenia 63 underlying vasculopathy 63 dirucotide MBP# 63 clinical pharmacology studies 63 epigenetic therapies 63 PRTX 63 cardiovascular metabolic 63 HCV polymerase inhibitors 63 ISTODAX 63 ThermoDox ® clinical 63 Exherin TM 63 HCV NS5B polymerase 63 PNP inhibitor 63 Proellex TM 63 cathepsin K inhibitor 63 invasive candidiasis 63 ularitide 63 MYLOTARG 63 cirrhosis liver failure 63 Phase III multicenter 63 Epiphany Biosciences 63 MKC# 63 atacicept 63 IAP inhibitor 63 ongoing Phase IIIb 63 AEGR 63 therapeutic monoclonal antibodies 63 radiolabeled TM# 63 oral deforolimus 63 Intarcia 63 Yondelis ® 63 Vitaxin 63 thiazolides 63 ONCONASE R 63 delivery polymer matrix 63 HGS# 63 Ganetespib 63 Intravenous CP 63 Temsirolimus 63 humanised monoclonal antibody 63 Initiates Clinical Trial 63 myeloproliferative neoplasms 63 cutaneous T 63 Crofelemer budesonide foam 63 vivo validation 63 substantially excreted 63 biodefense pathogens 63 trial evaluating PRX# 63 HCV protease inhibitors 63 Phase #/#a trial 63 lumiliximab 63 EchoCRT 63 Revimmune TM 63 Alferon LDO 63 hematologic disorders 63 Adenosine Therapeutics 63 cytokine refractory 63 LymphoStat B TM 63 gefitinib Iressa 63 transplantation HSCT 63 psoriatic arthritis PsA 63 Elvitegravir 63 Quinamed 63 Tofacitinib 63 oral JAK#/JAK# inhibitor 63 idiopathic thrombocytopenic purpura ITP 63 hyperphenylalaninemia HPA due 63 MELAS 63 Fc fusion protein 63 multicenter Phase III 63 Symadex 63 EndoTAG TM 63 etanercept Enbrel 63 KuDOS 63 humanized monoclonal antibody 63 endothelin antagonist 63 Mipomersen 63 Initiates Enrollment 63 apricitabine 63 severe hypercholesterolemia 63 Trovax 63 ThermoDox R 63 RezularTM 63 Entereg R 63 Dalbavancin 63 MT#/MEDI-# 63 Alitretinoin 63 Zometa zoledronic acid 63 Invasive pneumococcal disease 63 vaginal candidiasis 63 Selective Electrochemical Tumor Ablation 63 ACTEMRA TM 63 Phase IIIb clinical 63 HuMax CD4 63 BioMarck 63 antisense inhibitors 63 tramiprosate Alzhemed TM 63 benign prostatic hypertrophy BPH 63 ulimorelin 63 ALN TTR 63 signal transduction inhibitors 63 ProMune 63 atherothrombosis 63 rxRNA 63 clevidipine 63 pharmacokinetic PK study 63 dermatologic diseases 63 Moxifloxacin 63 Liver transplantation 63 Vitrasert R 63 relapsed leukemia 63 immunotherapeutic vaccine 63 DIFICID ™ 63 brivanib 63 MGd 63 Solazed TM 63 oral ghrelin agonist 63 peptibody 63 Talabostat 63 Crofelemer 63 Selzentry Celsentri 63 metastatic colorectal 63 hepatitis C viral infection 63 Pulmonary arterial hypertension 63 Vandetanib 63 Ribavirin causes 63 cognitive impairment associated 63 CRMD# 63 Tyrima 63 GVAX ® 63 liver transplantations 63 Systemic lupus erythematosus SLE 63 unresectable liver cancer 63 antibiotic Tygacil 63 Chronic hepatitis C 63 Immune Tolerance Network 63 Eculizumab 63 Telavancin 63 PrevOnco ™ 63 Diabetic Macular Edema DME 63 Trophos 63 fusion enhancers 63 Alfimeprase 63 candidate CRLX# 63 CHAMPION PCI 63 posaconazole 63 Zollinger Ellison Syndrome 63 Pimavanserin 63 GSK '# 63 velafermin 63 DGAT1 inhibitors 63 Serdolect ® 63 cyclophilin inhibitor 63 multi kinase inhibitor 63 non cirrhotic portal 63 eritoran 62 nephropathic cystinosis 62 BrachySil ™ 62 IMiD 62 peripherally acting 62 renin inhibitors 62 pan histone deacetylase 62 Ceflatonin 62 herpetic keratitis 62 sJIA 62 HMG CoA reductase inhibitors 62 immunotherapeutic approaches 62 echinocandin 62 JAK3 62 Neulasta R 62 mTOR kinase 62 treat chronic sinusitis 62 PAOD 62 topically applied SEPA 62 Ozarelix 62 Amgen Neulasta R 62 Val HeFT 62 Vectibix panitumumab 62 budesonide foam 62 Vegenics 62 Panzem ® 62 Pagoclone 62 RECOTHROM R 62 intra abdominal infections 62 Zenvia ™ 62 Bioaccelerate compounds under 62 Alinia 62 FoldRx 62 antibiotic resistant bacterial infections 62 selective S#P# receptor agonist 62 novel peptides 62 Albugon 62 Raptiva R 62 erlotinib Tarceva ® 62 secondary hyperparathyroidism 62 erythematosus 62 metastatic malignant 62 Xcytrin R 62 interferon gamma 1b 62 Glufosfamide 62 PI3K/Akt pathway inhibitor 62 Chronic HCV infection 62 recombinant biopharmaceutical 62 Teriflunomide 62 hematologic diseases 62 Cancidas 62 Nasdaq IDIX biopharmaceutical 62 vaccine GRNVAC1 62 MAA submission 62 Alvine Pharmaceuticals 62 novel therapeutic antibodies 62 Ocrelizumab 62 Anidulafungin 62 candidate deforolimus 62 HBeAg negative 62 Lymphoseek ® 62 virosome 62 PEGylated interferon beta 1a 62 immune modulator 62 Viprinex TM 62 TBC# 62 cytomegalovirus infection 62 NASH Huntington 62 Enzyme Replacement Therapy 62 bevacizumab Avastin ® 62 candidates Azedra TM 62 photodisinfection 62 Gamunex C 62 EnzymeRx 62 non nucleoside HCV 62 haematologic malignancies 62 clinically heterogeneous 62 regorafenib 62 CDP# 62 Elagolix 62 AGGRASTAT R tirofiban hydrochloride 62 HCD# [002] 62 Nanobody R 62 histone deacetylase HDAC inhibitor 62 novel antiviral therapeutics 62 Veronate 62 coagulation disorders 62 multicenter trials 62 radiotherapeutic 62 ZADAXIN ® 62 lomitapide 62 hypereosinophilic syndrome 62 oral antiviral 62 calcineurin inhibitors 62 Prodarsan ® 62 ONTARGET 62 BENLYSTA ® 62 XL# anticancer compounds 62 Octreolin 62 indinavir Crixivan 62 eprotirome 62 vidofludimus 62 pain palliation 62 PSN# [002] 62 UPLYSO 62 Pseudomonas aeruginosa infections 62 product Fentanyl TAIFUN 62 EMPOWER ™ 62 refractory gout 62 albiglutide 62 Diabetic Macular Edema 62 Bronchiectasis 62 Pafuramidine 62 Arno Therapeutics 62 lymphoid malignancies 62 lucinactant 62 haematological cancers 62 demyelinating disease 62 SagaX 62 CBLC# 62 Kosan dependence 62 BCR ABL inhibitors 62 Vascugel 62 Alessandro Riva 62 SUTENT 62 Cloretazine R 62 CMV vaccine 62 Silodosin 62 delivers fluocinolone acetonide FA 62 sodium glucose cotransporter 62 Epratuzumab 62 neuropathic pain spasticity 62 Exelixis compounds 62 diabetic kidney 62 anti PlGF 62 delafloxacin 62 virus HCV protease inhibitor 62 Dacogen decitabine 62 cMET 62 relapsed multiple myeloma 62 Oral NKTR 62 Valvular heart 62 formerly LymphoStat B 62 humanized monoclonal 62 diabetic neuropathic pain 62 Dacetuzumab 62 ZEVALIN ® 62 chronic HCV infection 62 Viral Immunotherapy platform 62 noninfectious uveitis 62 Neulasta ® 62 MGN# 62 Pegloticase 62 inflammatory autoimmune 62 Zolinza 62 Fresenius Biotech 62 GERD migraine headaches 62 MEK inhibitors 62 Achieves Primary Endpoint 62 pertuzumab 62 Acute Bacterial Sinusitis ABS 62 humanized anti 62 BHT DNA 62 MyVax ® 62 Nitazoxanide 62 delay bone metastases 62 Plicera 62 refractory chronic lymphocytic 62 novel immunotherapies 62 Serostim ® 62 inflammatory autoimmune diseases 62 toenail onychomycosis 62 thromboembolic disease 62 Diabetic nephropathy 62 psoriasis inflammatory bowel 62 leading oral taxane 62 AzaSite Plus 62 catheter occlusion 62 oral picoplatin 62 heterozygous FH 62 Initiates Phase II 62 Blinatumomab 62 Hepatitis C HCV 62 post herpetic neuralgia PHN 62 ERYtech 62 RNAi therapeutic platform 62 systemic autoimmune 62 fluoroquinolone antibiotic 62 Geodon ziprasidone 62 myeloproliferative diseases 62 Uricase PEG 62 SUCCEED trial 62 Phase IIb trials 62 sorafenib tablets 62 anti amnesic 62 Initiates Phase III 62 Roche PEGASYS R 62 vitreoretinal disorders 62 ALTROPANE R 62 receptor inhibitor 62 targeting CD# 62 oral dual endothelin 62 Carfilzomib 62 Phase #/#a 62 Alemtuzumab 62 BENLYSTA TM 62 terlipressin 62 immune modulators 62 Reverset 62 Certican 62 relapsing remitting MS RRMS 62 ASX PGL 62 IgG1 monoclonal antibody 62 sitaxsentan 62 AKT inhibitor 62 inhibitor RG# 62 ovarian prostate 62 CINQUIL 62 samarium Sm 62 recombinant interferon 62 trastuzumab Herceptin R 62 Elotuzumab 62 Myelofibrosis 62 CIMZIA TM 62 Desvenlafaxine 62 nucleotide analog 62 Prednisporin 62 DPP4 inhibitor 62 Aganocide 62 treatment naïve genotype 62 FUSILEV ® 62 pediatric acute lymphoblastic 62 PDE4 inhibitor 62 AVONEX ® 62 molecular imaging radiopharmaceutical 62 phase Ib clinical 62 C1 esterase inhibitor 62 ACOMPLIA R 62 StemEx 62 2 methoxyestradiol 62 REG1 62 Enkephalin 62 metastatic GIST 62 prospective multicenter study 62 Bayer HealthCare Onyx Pharmaceuticals 62 orally bioavailable mimics 62 oral prodrug 62 HIV integrase inhibitors 62 pemphigus vulgaris 62 blinded randomized placebo controlled 62 Aplidin 62 Vernakalant 62 novel immunomodulatory 62 INTEGRILIN ® 62 Glypromate 62 Curaxin CBLC# 62 pacemakers implantable cardioverter defibrillatorsHELB 62 herpes zoster shingles 62 SNT-MC#/idebenone 62 autoimmune inflammatory 62 chemotherapy induced thrombocytopenia 62 anti fibrotic 62 histone deacetylase HDAC inhibitors 62 Cariprazine 62 myelodysplastic myeloproliferative diseases 62 candidate epratuzumab 61 thrombolytic agent 61 Neogenix 61 dermatological diseases 61 CD# monoclonal antibody 61 Febuxostat 61 Antisoma AS# 61 Muraglitazar 61 Hypertriglyceridemia 61 Litx 61 Tezampanel 61 bardoxolone 61 oral RSD# 61 candidate XP# 61 Phase Ib IIa 61 atypical Hemolytic Uremic Syndrome 61 huC# DM4 61 Dacogen injection 61 antitumoral 61 RE LY ® 61 lung liver pancreas 61 MYDICAR ® 61 retinal vein occlusion induced 61 oncological indications 61 acute coronary syndromes ACS 61 neuro inflammatory 61 Clolar ® 61 telaprevir VX 61 Vidaza R 61 beta secretase inhibitors 61 pralatrexate injection folate analogue 61 antisense drug 61 Factor Xa inhibitor 61 aurora kinase 61 gastrointestinal disorders ATI 61 PNT# 61 CureDM 61 cell lymphoma CTCL 61 INOmax R 61 TG MV 61 plasma protein biotherapeutics 61 cutaneous lupus 61 complement inhibitor eculizumab 61 candidate TNFerade biologic 61 cystic fibrosis chronic pancreatitis 61 Syntonix 61 ocular inflammatory 61 RhuDex 61 p# inhibitor 61 Nanobody 61 vWD 61 BMS # 61 protein misfolding diseases 61 ATG Fresenius S 61 selective inhibition 61 Amrubicin 61 Warfarin Coumadin 61 renal failure interstitial lung 61 Ticagrelor 61 Phase 2a Clinical Trial 61 autoimmune uveitis 61 enzastaurin 61 damage cirrhosis liver 61 unresectable tumors 61 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 61 Pertuzumab 61 vascular disrupting agent 61 chemotherapy induced neutropenia 61 cediranib 61 rheumatoid arthritis inflammatory bowel 61 antithrombotic agent 61 immune modulatory 61 immunoregulation 61 Hepatocellular Carcinoma 61 Hepatitis C Virus HCV 61 trastuzumab DM1 T DM1 61 Etubics 61 vaso occlusive crisis 61 Avila Therapeutics 61 PF # [002] 61 Protexia ® 61 CEQ# 61 Viprinex 61 Romiplostim 61 Genentech Rituxan 61 investigational HCV polymerase 61 phase IIb 61 Granulocyte Colony Stimulating Factor 61 Cethrin 61 GENASIS 61 Pivotal Trial 61 hematologic malignancies 61 CINTREDEKIN BESUDOTOX 61 staphylococcal vaccine 61 Tykerb lapatinib 61 immunomodulation 61 Belimumab 61 selective modulator 61 XL# XL# 61 Inhaled nitric oxide 61 INTEGRILIN R eptifibatide Injection 61 anti angiogenic agents 61 ENMD # 61 Diabetic Neuropathy 61 small molecule thrombopoietin 61 axitinib 61 Nonalcoholic fatty liver 61 Traficet EN 61 BCR ABL inhibitor 61 Mg Usa 61 advanced hepatocellular carcinoma 61 Aerosurf 61 candidates bavituximab 61 KL4 Surfactant 61 Clostridium difficile associated 61 hepatocellular carcinoma liver 61 Cloretazine 61 beta blockers ACE inhibitors 61 LymphoStat B 61 ENTOCORT EC 61 hematological malignancy 61 Allovectin 7 R 61 diabetic nephropathy 61 isoform selective 61 mitogen activated ERK kinase 61 Ancrod 61 protein kinase inhibitors 61 NYHA Class II 61 visilizumab 61 5 HT6 receptor 61 Gleevec imatinib mesylate 61 Telatinib 61 Foradil Aerolizer 61 HepaGam B TM 61 Somatuline Depot 61 Homspera TM 61 rNAPc2 61 PREVENAR 61 hepatocellular liver 61 ESBA# 61 epothilones 61 selective immunoproteasome inhibitor 61 GRNCM1 61 Fibrillex TM 61 immunopathology 61 aerosolized KL4 surfactant 61 primary hyperparathyroidism 61 Receptos 61 TransVax ™ 61 dasatinib Sprycel ® 61 Bicifadine 61 Orally administered 61 blood clot dissolver 61 gastrointestinal mucositis 61 TransVax TM 61 fosbretabulin 61 metaglidasen 61 StromaCel Inc. 61 Combination REOLYSIN R 61 nucleotide analogue 61 EVIZON TM 61 VivaGel ™ 61 Hodgkin lymphoma HL 61 Zemplar Capsules 61 Genasense evaluating 61 Medidur ™ FA 61 Curaxin 61 delivered RNAi therapeutic 61 Certolizumab pegol 61 ixabepilone 61 PSMA ADC 61 Mersana 61 OncoVEX GM CSF 61 Mycamine 61 personalized immunotherapy 61 Myelodysplastic Syndrome MDS 61 pediatric Crohn disease 61 IMiDs 61 PSN# [001] 61 Corlux 61 Lubiprostone 61 Safinamide 61 heparin induced thrombocytopenia 61 nucleoside analogs 61 Catena ® 61 PORxin TM platforms 61 ProLindac TM 61 ALN TTR# 61 myeloproliferative neoplasms MPNs 61 Rasilez Tekturna 61 oral beclomethasone dipropionate 61 vemurafenib 61 HepeX B TM 61 Janus kinase 61 RE LY 61 casopitant 61 Diamyd ® 61 Cerashield 61 neurology immunology 61 CRVO 61 Vidaza azacitidine 61 acute humoral rejection 61 hypersensitivity allergic reactions 61 chronic eosinophilic leukemia 61 postoperative ileus 61 lintuzumab SGN 61 Velcade bortezomib 61 oral Factor Xa 61 KIACTA ™ 61 delta opioid receptor 61 miconazole Lauriad ® 61 EXPLORE Xa 61 OMNARIS HFA 61 DDP# 61 depsipeptide 61 RECOTHROM ® 61 Phase 1b clinical trials 61 immuno inflammatory 61 Gleevec Glivec 61 ALK inhibitors 61 agonistic human 61 NCCTG 61 Retigabine 61 NovaBay Aganocide compounds 61 chronic constipation CC 61 Tibotec BVBA 61 Thalomid ® 61 recurrent metastatic ovarian cancer 61 Acute Coronary Syndromes ACS 61 vascular disrupting agents 61 myocardial infarction ventricular fibrillation 61 hypervascular tumors 61 paclitaxel Taxol ® 61 Sutent sunitinib 61 Recombinant interferon alpha 61 HCV polymerase 61 Receives Orphan Drug Designation 61 subcutaneous immunoglobulin 61 novel histone deacetylase 61 Zarnestra 61 severe gastroparesis 61 highly selective inhibitor 61 ovarian breast 61 Sapacitabine 61 Atrasentan 61 respiratory gastrointestinal 61 micafungin 61 paclitaxel poliglumex 61 OZURDEX ® 61 oral JAK1 61 Insegia 61 novel anti infective 61 systemic juvenile idiopathic 61 Severe VOD 61 DCVax R 61 HuCNS SC ® 61 Zenpep 61 BEXXAR Therapeutic Regimen 61 muscular dystrophies 61 immuno oncology 61 By JENNIFER LEARN 61 castrate resistant prostate cancer 61 TMS Therapy 61 EDEMA3 61 Methylnaltrexone 61 TG# [003] 61 Lymphocytic 61 Peginterferon alfa 2b 61 blood coagulation disorders 61 oxaliplatin Eloxatin 61 Stapled Peptide 61 HepeX B 61 Thiovir